Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
NVS
NVS
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
NVS News
Analysis of International Stock Investment Opportunities
9h ago
Fool
Vanguard Total International Stock ETF Valuation Gap Widens
9h ago
NASDAQ.COM
Teva Pharmaceuticals Transitions to Innovative Drug Development
1d ago
Fool
Teva Pharmaceuticals Reports Strong Q1 Performance
1d ago
NASDAQ.COM
U.S. Launches Investigation into Germany's Pharma Policies
1d ago
CNBC
Biotech IPO Market Reopens Amid M&A Surge
4d ago
CNBC
Biotech Investors Become More Selective Amid Market Changes
4d ago
Newsfilter
Switzerland's Population Cap Referendum Sparks Controversy
Jun 13 2026
CNBC
Novartis RNA Therapy Del-Brax Shows Success in Muscular Dystrophy Trial
Jun 12 2026
seekingalpha
Novartis Expands Deal with Orionis for Molecular Glue Drugs
Jun 11 2026
seekingalpha
Update: US Equity Futures Rise Pre-Bell After US Says Strikes Completed Against Iran
Jun 11 2026
Yahoo Finance
Performance Analysis of iShares International ETFs
Jun 10 2026
NASDAQ.COM
Analysis of Growth Potential in International ETFs
Jun 10 2026
Fool
GSK Acquires Lung Cancer Biotech Nuvalent for $10.6 Billion
Jun 09 2026
Yahoo Finance
GSK in Talks to Acquire Nuvalent for Over $9 Billion
Jun 09 2026
CNBC
Novartis' Vanrafia Significantly Slows Kidney Function Decline in IgAN Patients
Jun 04 2026
NASDAQ.COM
Show More News
